| A unique subset of CD4+ CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-β1 mediates suppression in the tumor microenvironment L Strauss, C Bergmann, M Szczepanski, W Gooding, JT Johnson, ... Clinical Cancer Research 13 (15), 4345-4354, 2007 | 559 | 2007 |
| Selective survival of naturally occurring human CD4+ CD25+ Foxp3+ regulatory T cells cultured with rapamycin L Strauss, TL Whiteside, A Knights, C Bergmann, A Knuth, A Zippelius The Journal of Immunology 178 (1), 320-329, 2007 | 425 | 2007 |
| Revisiting the PD-1 pathway N Patsoukis, Q Wang, L Strauss, VA Boussiotis Science advances 6 (38), eabd2712, 2020 | 360 | 2020 |
| Targeted deletion of PD-1 in myeloid cells induces antitumor immunity L Strauss, MAA Mahmoud, JD Weaver, NM Tijaro-Ovalle, A Christofides, ... Science immunology 5 (43), eaay1863, 2020 | 346 | 2020 |
| Increased frequency and suppression by regulatory T cells in patients with acute myelogenous leukemia MJ Szczepanski, M Szajnik, M Czystowska, M Mandapathil, L Strauss, ... Clinical cancer research 15 (10), 3325-3332, 2009 | 335 | 2009 |
| The frequency and suppressor function of CD4+ CD25highFoxp3+ T cells in the circulation of patients with squamous cell carcinoma of the head and neck L Strauss, C Bergmann, W Gooding, JT Johnson, TL Whiteside Clinical cancer research 13 (21), 6301-6311, 2007 | 322 | 2007 |
| Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma TE Reichert, L Strauss, EM Wagner, W Gooding, TL Whiteside Clinical cancer research 8 (10), 3137-3145, 2002 | 296 | 2002 |
| Human circulating CD4+ CD25highFoxp3+ regulatory T cells kill autologous CD8+ but not CD4+ responder cells by Fas-mediated apoptosis L Strauss, C Bergmann, TL Whiteside The Journal of Immunology 182 (3), 1469-1480, 2009 | 255 | 2009 |
| The complex role of tumor-infiltrating macrophages A Christofides, L Strauss, A Yeo, C Cao, A Charest, VA Boussiotis Nature immunology 23 (8), 1148-1156, 2022 | 247 | 2022 |
| Differential responses of human regulatory T cells (Treg) and effector T cells to rapamycin L Strauss, M Czystowska, M Szajnik, M Mandapathil, TL Whiteside PloS one 4 (6), e5994, 2009 | 201 | 2009 |
| Expression of ICOS on human melanoma-infiltrating CD4+ CD25highFoxp3+ T regulatory cells: implications and impact on tumor-mediated immune suppression L Strauss, C Bergmann, MJ Szczepanski, S Lang, JM Kirkwood, ... The Journal of Immunology 180 (5), 2967-2980, 2008 | 194 | 2008 |
| T regulatory type 1 cells in squamous cell carcinoma of the head and neck: mechanisms of suppression and expansion in advanced disease C Bergmann, L Strauss, Y Wang, MJ Szczepanski, S Lang, JT Johnson, ... Clinical Cancer Research 14 (12), 3706-3715, 2008 | 192 | 2008 |
| Expansion of human T regulatory type 1 cells in the microenvironment of cyclooxygenase 2 overexpressing head and neck squamous cell carcinoma C Bergmann, L Strauss, R Zeidler, S Lang, TL Whiteside Cancer research 67 (18), 8865-8873, 2007 | 190 | 2007 |
| RORC1 regulates tumor-promoting “emergency” granulo-monocytopoiesis L Strauss, S Sangaletti, FM Consonni, G Szebeni, S Morlacchi, MG Totaro, ... Cancer cell 28 (2), 253-269, 2015 | 188 | 2015 |
| Targeting T cell metabolism for improvement of cancer immunotherapy T Le Bourgeois, L Strauss, HI Aksoylar, S Daneshmandi, P Seth, ... Frontiers in oncology 8, 237, 2018 | 159 | 2018 |
| Tumor‐derived microvesicles in sera of patients with head and neck cancer and their role in tumor progression C Bergmann, L Strauss, E Wieckowski, M Czystowska, A Albers, Y Wang, ... Head & neck 31 (3), 371-380, 2009 | 131 | 2009 |
| Expansion and characteristics of human T regulatory type 1 cells in co-cultures simulating tumor microenvironment C Bergmann, L Strauss, R Zeidler, S Lang, TL Whiteside Cancer Immunology, Immunotherapy 56, 1429-1442, 2007 | 126 | 2007 |
| Effects of adjuvant chemoradiotherapy on the frequency and function of regulatory T cells in patients with head and neck cancer PJ Schuler, M Harasymczuk, B Schilling, Z Saze, L Strauss, S Lang, ... Clinical cancer research 19 (23), 6585-6596, 2013 | 110 | 2013 |
| Dual role of VEGF family members in the pathogenesis of head and neck cancer (HNSCC): possible link between angiogenesis and immune tolerance. L Strauss, D Volland, M Kunkel, TE Reichert Medical science monitor: international medical journal of experimental and …, 2005 | 110 | 2005 |
| Origin and functions of tumor-associated myeloid cells (TAMCs) A Sica, C Porta, S Morlacchi, S Banfi, L Strauss, M Rimoldi, MG Totaro, ... Cancer Microenvironment 5, 133-149, 2012 | 101 | 2012 |
